Pfizer’s dealmaking continues as GBT, Biohaven acquisitions close

Pfizer’s robust M&A activity continues as the pharma giant has closed two deals totaling a combined $17 billion this week.

Pfizer announced Wednesday morning that it closed its $5.4 billion deal to acquire Global Blood Therapeutics, two days after announcing that it closed its $11.6 billion deal to purchase Biohaven Pharmaceuticals.